ImmunityBio, Inc. (NASDAQ:IBRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Bruce Wendel Other companies: GT Biopharma, Inc. (Director · Nov 11, 2020 – Jan 27, 2023 · Past); Verastem, Inc. (Director · Jun 14, 2016 – Jun 16, 2020 · Past); Abraxis BioScience Inc (Chief Executive Officer, Director · Nov 7, 2007 – Oct 15, 2010 · Past) | Director · Since at least Dec 12, 2025 |
| Barry Simon Other companies: Viracta Therapeutics Inc (Director · Mar 3, 2021 – Jun 20, 2024 · Past); Cue Biopharma, Inc. (Director · Jan 4, 2021 – Jan 4, 2021 · Past) | Director · Since at least Dec 22, 2020 |
| Michael Blaszyk Other companies: Nanthealth LLC (Director · Jun 1, 2016 – Jun 9, 2022 · Past); APP Pharmaceuticals Inc (Director · Aug 1, 2006 – Sep 10, 2008 · Past) | Director · Since at least Jul 27, 2015 |
| Robert Rosen Other companies: La Jolla Pharmaceutical Co (Director · Jul 7, 2014 – Aug 22, 2022 · Past); Heron Therapeutics, Inc. (President, Director · May 1, 2013 – Dec 15, 2018 · Past) | Director · Jul 27, 2015 – Jul 27, 2015 · Past |
| Sonja Nelson Other companies: Ambrx Biopharma Inc. (Chief Financial Officer · Jan 1, 2023 – Mar 7, 2024 · Past); Motus GI Holdings, Inc. (Director · Jun 22, 2021 – Mar 5, 2024 · Past) | Chief Financial Officer · Aug 2, 2019 – Jan 12, 2021 · Past |
| Cheryl L. Cohen Other companies: Celldex Therapeutics, Inc. (Director · Since at least Jun 13, 2024) | Director · Since at least Jun 11, 2024 |
| Linda Maxwell Other companies: United Therapeutics Corporation (Director · Since at least Jul 8, 2021) | Director · Since at least Mar 29, 2021 |
| Regan Lauer Other companies: Banc of California, Inc. (SVP - CONTROLLER · Dec 31, 2008 – Oct 23, 2012 · Past) | Chief Accounting Officer · Since at least Nov 9, 2021 |
| Richard J Tajak Other companies: APP Pharmaceuticals Inc (Exec. VP & CFO · Apr 29, 2008 – Sep 10, 2008 · Past) | Chief Financial Officer · Jan 20, 2016 – Mar 23, 2017 · Past |
| Wesley Clark Other companies: Blue Acquisition Corp. (Director · Since at least Jun 12, 2025) | Director · Since at least Jun 14, 2022 |
| Bruce Brown | Senior Vice President, Medical Affairs · Since at least Apr 21, 2025 |
| Charles G. Garlisi | Senior Vice President, Regulatory Affairs · Since at least Nov 5, 2026 |
| Christobel Selecky | Director · Since at least Jun 29, 2026 |
| David Sachs | Chief Financial Officer · Since at least Nov 5, 2026 |
| Elizabeth Gabitzsch | Senior Vice President, Product Development & Vaccine Programs · Since at least Nov 5, 2026 |
| Emily Arison | Senior Vice President of Human Resources · Since at least Nov 5, 2026 |
| Enrique Diloné | Chief Technology Officer · Since at least Nov 5, 2026 |
| Hemanth Ramaprakash | Investor Relations · Since at least May 7, 2026 |
| Jim Yong Kim | Vice Chairman · Since Aug 10, 2026 · Appointed, no departure found |
| Jim Yong Kim | Vice Chairman · Since at least Aug 10, 2026 |
| John Owen Brennan | Director · Mar 9, 2021 – Jun 11, 2024 · Past |
| Leonard S. Sender | Chief Medical Officer, Liquid Tumors & Cell Therapy · Since at least Nov 5, 2026 |
| Manju Saxena | Senior Vice President of Product Development, Cell Therapy Program · Since at least Nov 5, 2026 |
| Matthew Hilman | Vice President US Commercial – Urologic Oncology · Since at least Nov 5, 2026 |
| Patrick Soon-Shiong | Executive Chairman of the Board · Since at least Oct 21, 2026 |
| Rich Adcock | President & Chief Executive Officer · Since at least Jan 14, 2026 |
| Richard Adcock | CEO & President, Director · Since at least Dec 31, 2023 |
| Richard Kusserow | Director · Jun 9, 2017 – Jun 9, 2017 · Past |
| Sandeep Bobby Reddy | Chief Medical Officer · Since at least Apr 21, 2025 |
| Sarah Singleton | Chief Communications Officer & Head of Patient Advocacy · Since at least Oct 8, 2026 |